Drug Approvals
🇺🇸 FDA Page 37FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 433–444 of 665 articles
NICE Approves Imfinzi for Stomach Cancer: What It Means for Investors
UCB Acquires Antibody Treatment Maker: Implications for Autoimmune Disease Market
Big Pharma M&A Set for Mega Year Amid Patent Expiries
Doceree Launches Daily Command: An AI Revolution for Pharma Brand Teams
When Should You Get a Mammogram? Navigating Conflicting Advice
Hantavirus Outbreak: Lessons from COVID-19 for Pharma
Sen. Bill Cassidy Loses Primary: Implications for Pharma
FDA Leadership Changes Crisis: Implications for Drug Approvals
Ebola Exposure Risk: Implications for Pharma Stakeholders
FDA Shake-Up: Implications for Oncology and Beyond
Leadership Changes at CDER and CBER: Implications for Oncology
Pharma M&A Round-Up: April 2026 Insights and Analysis